ACTRN12624000504516Not yet recruitingUnknown
Effect of levocarnitine supplementation on quality of life amongst patients on maintenance haemodialysis for end stage renal disease
Dr. Obaid Ur Rehman, Pak Emirates Military Hospital Rawalpindi Pakistan0 sites24 target enrollmentStarted: April 24, 2024Last updated:
Conditions
Trial Snapshot
- Phase
- Unknown
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 24
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomised controlled trial
- Primary Purpose
- Treatment
- Masking
- Blinded (masking used)
Eligibility Criteria
- Ages
- 12 Years to o limit (—)
- Sex
- All
Inclusion Criteria
- •(1)Patients diagnosed with end-stage renal disease undergoing maintenance haemodialysis two times a week for at least 3 months.
- •(2)Patients willing to participate and provide informed consent.
Exclusion Criteria
- •(1) Patients with a history of allergic reactions to levocarnitine.
- •(2) Patients who have received L-carnitine therapy in previous 3 months.
- •(3) Patients with cognitive difficulties who are unable to comprehend questions on the SF-36 questionnaire
- •(4) Limited mobility
Investigators
Similar Trials
Recruiting
Phase 3
Evaluation the effects of L Carnitine on quality of life of the cirrhotic patientsIRCT20180313039075N1Shahid Beheshti University of Medical Sciences120
Completed
Not Applicable
Clinical efficacy of levocarnitine supplementation in patients with hemodialysisHemodialysis patientsJPRN-UMIN000015185Keiai Hospital100
Not yet recruiting
Phase 3
Role of Levocarnitine supplementation on recovery in children with Complicated Severe Acute MalnutritioCTRI/2022/10/046683Indian Council of Medical Research
Recruiting
Phase 3
Effect of L-carnitine in Ischemic StrokeIschemic stroke.Cerebral infarctionIRCT20221206056734N1Ahvaz University of Medical Sciences82
Recruiting
Phase 3
The Effect of L-Carnitine supplementation administration rout on the prognosis of patientsPatients admitted to the intensive care unit.Follow-up examination after unspecified treatment for other conditionsZ09.9IRCT20170903036041N4Iran University of Medical Sciences135